Immediate Impact

55 standout
Sub-graph 1 of 22

Citing Papers

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
2018 Standout
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
2017 Standout
4 intermediate papers

Works of M. Zanini being referenced

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
1997
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
1996

Author Peers

Author Last Decade Papers Cites
M. Zanini 461 214 299 23 630
Ferial Shihadeh 322 122 246 17 559
M. Vera Peters 414 138 274 23 680
Patrizia Gentilini 380 85 369 24 604
Delia Rota Scalabrini 435 133 282 23 575
Luca Nassi 502 164 189 38 653
Simone Snijder 388 76 232 24 596
Martin Soekler 390 181 268 23 604
Marcel Hayat 258 135 157 20 570
M. Hoffmann 504 153 206 19 653
Patrizia Albertini 566 137 257 17 699

All Works

Loading papers...

Rankless by CCL
2026